Betanidin significantly reduces blood glucose levels in BALB/c mice fed with an atherogenic diet

作     者：Agustin LUGO-RADILLO Ivan DELGADO-ENCISO Elpidio PEÑA-BELTRÁN 

作者机构：Instituto Nacional de GeriatríaPeriférico Sur 2767San Jerónimo LídiceMagdalena Contreras10200 México D.F.México Facultad de MedicinaUniversidad de ColimaAv.Universidad 333Colonia Las Víboras28040 ColimaColimaMéxico Facultad de Ciencias Biológicas y AgropecuariasUniversidad de Colima.Carr.Colima-Manzanillo km 4028100 TecománColimaMéxico 

出 版 物：《Natural Products and Bioprospecting》 (应用天然产物（英文）)

年 卷 期：2012年第2卷第4期

页      面：154-155页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：betalains betanidin blood glucose hypoglycemiant 

摘      要：Six weeks BALB/c mice were fed with an atherogenic diet for 24 weeks and purified water ad *** experimental group was given betanidin,orally,during the last 40 days of the experiment at a dose of 9.6 mg per mouse per *** controls were fed with standard rodent chow *** was measured at the end of the experiment,after overnight *** group treated with betanidin presented a highly significant reduction of 50.94%compared to positive *** conclude that betanidin reduces glycemia in BALB/c mice by an unidentified mechanism.